- Home
- Companies
- Laxxon Medical
- Services
Laxxon Medical services
New Drug Development Solutions
Laxxon serves as a research, development, engineering, and manufacturing partner for pharmaceutical companies seeking new drug development. SPID®-Technology can produce small batch sizes for R&D and clinical studies, which can then be scaled to an industrial standard of production without a change in the manufacturing process.
Advanced Patented Generics Services
Through our proprietary SPID®-Technology, we can repurpose, reposition, and relaunch generic APIs with patent protection while also addressing common issues with generic drugs such as patient compliance, dosage, and side effects. Our Advanced Patented Generics are going to be registered in the US under the FDA Section 505(b)(2), a fast-tracked regulatory approval process. In the EU, our Advanced Patented Generics will be registered as the Hybrid applications under Article 10(3) of Directive 2001/83/EC.
Patent Extension Services
Laxxon offers pharmaceutical companies whose products are facing patent expiration an opportunity to “extend” their patents through Technology Transfer. Our additive manufacturing approach enables the optimization and reformulation of such pharmaceutical products, which are then protected by the Laxxon IP.
